Hence, increasing evidence suggests that overexpression of ITGAV is associated with tumor progression and poor prognosis in various malignancies, including glioblastoma17, hepatocellular carcinoma18, breast cancer19, colorectal cancer20, and lung cancer21; gastric cancer22; prostate cancer23; and head and neck squamous cell carcinoma24. The gene discussed is ITGAV; the disease is neoplasm.